Patient Portal

Charles R. Conway, MD

Professor, Psychiatry

Specialty Areas

Adult Psychiatry
Mood Disorders
Depression

Board Certifications

Psychiatry

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Vagus nerve stimulation for treatment resistant depression, bipolar disorder, mood disorders.

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Office Phone: 314-286-1700
Fax: 314-362-7017

Education

Education

B.A.: Psychology, St. Louis University, St. Louis, Missouri 1987
Medical Degree: University of Missouri-Columbia, Columbia, Missouri 1995
Residency: Psychiatry, Duke University Medical Center, Durham, North Carolina 1999

Publication & Research

Publication & Research

Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality. Am J Psychiatry, 2017 Mar. PMID: 28359201.  

Conway CR, George MS, Sackeim HA. Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough. JAMA Psychiatry, 2017. 74(1): 9-10. PMID: 27784055.  

Conway CR, Gebara MA, Walker MC, Lessov-Schlaggar CN, Janski AM, Chibnall JT, Cristancho P, Sheline YS, Gott BM, Svrakic DM. Clinical Characteristics and Management of Treatment-Resistant Depression. J Clin Psych, 2015; Nov; 76(11): 1569-70. PMID: 26646033.

Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, Janski A, Panagopoulos VN, Cristancho P, Miller JP, Zorumski CF, Conway CR. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial. Biological Psychiatry. 2015; Jul 1; 78(1). PMID: 25577164.

Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI. Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimulation, 2013; 6(5): 788-97. PMCID: PMC3954813.

Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA. 
Cerebral Blood Flow Changes during Acute Vagus Nerve Stimulation for Depression.
Psychiatry Res: Neuroimaging, 2006; 146(2):179-184. PMID: 16510266.


Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Cyberonics/LivaNova

Royalties:

Equity: No

Consulting/Advisory Board: $20,000 - $39,999

Speaker Fees: $1 - $9,999

Reporting Date: May 01, 2019

Areas of Research Interest

Mood disorders, treatment-resistant depression, mechanism of action of neurostimulation treatments, and bipolar disorders.